Literature DB >> 12095464

Neuroendocrine abnormalities in fibromyalgia.

Gail K Adler1, Valdis F Manfredsdottir, Katharine W Creskoff.   

Abstract

Fibromyalgia is a disorder of unknown etiology characterized by chronic, widespread musculoskeletal pain and symptoms such as fatigue, poor sleep, gastrointestinal complaints, and psychologic problems that are similar to those experienced by patients with hormone deficiencies. This review summarizes the available data on the neuroendocrine function in fibromyalgia, including data on hormone secretion, circadian phase, and autonomic nervous system function. Studies suggest that there may be lower activity of a number of hypothalamic-pituitary-peripheral gland axes and altered autonomic nervous system function in patients with fibromyalgia. These reductions in activity are mild to moderate and do not result from alterations in circadian rhythms. The reduced hormonal and autonomic responses appear to reflect an impairment in the hypothalamic or central nervous system response to stimuli rather than a primary defect at the level of the pituitary gland or the peripheral glands. A combination of multiple, mild impaired responses may lead to more profound physiologic and clinical consequences as compared with a defect in only one system, and could contribute to the symptoms of fibromyalgia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12095464     DOI: 10.1007/s11916-002-0050-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  71 in total

1.  Dysautonomia among patients with fibromyalgia: a noninvasive assessment.

Authors:  S R Raj; D Brouillard; C S Simpson; W M Hopman; H Abdollah
Journal:  J Rheumatol       Date:  2000-11       Impact factor: 4.666

Review 2.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.

Authors:  D J Clauw; G P Chrousos
Journal:  Neuroimmunomodulation       Date:  1997 May-Jun       Impact factor: 2.492

3.  Orthostatic sympathetic derangement in subjects with fibromyalgia.

Authors:  M Martínez-Lavín; A G Hermosillo; C Mendoza; R Ortiz; J C Cajigas; C Pineda; A Nava; M Vallejo
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

4.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

5.  The effect of dim light on suppression of nocturnal melatonin in healthy women and men.

Authors:  P J Nathan; G D Burrows; T R Norman
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.

Authors:  F Cordido; C Dieguez; F F Casanueva
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

7.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

Authors:  A Korszun; L Sackett-Lundeen; E Papadopoulos; C Brucksch; L Masterson; N C Engelberg; E Haus; M A Demitrack; L Crofford
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

8.  Low urinary cortisol excretion in patients with posttraumatic stress disorder.

Authors:  R Yehuda; S M Southwick; G Nussbaum; V Wahby; E L Giller; J W Mason
Journal:  J Nerv Ment Dis       Date:  1990-06       Impact factor: 2.254

9.  Regulation of the renin-angiotensin-aldosterone system in fibromyalgia.

Authors:  Anne M Maliszewski; Don L Goldenberg; Shelley Hurwitz; Gail K Adler
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

10.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.

Authors:  E N Griep; J W Boersma; E R de Kloet
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

View more
  6 in total

Review 1.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 2.  Sleep disorders and fibromyalgia.

Authors:  Suely Roizenblatt; Nilton Salles Rosa Neto; Sergio Tufik
Journal:  Curr Pain Headache Rep       Date:  2011-10

3.  Sound stress-induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines.

Authors:  Sachia G Khasar; Olayinka A Dina; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2009-07-02       Impact factor: 5.820

4.  Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome.

Authors:  Ahmet Karadağ; Emrullah Hayta; Veysel Kenan Çelik; Sevtap Bakir
Journal:  Arch Rheumatol       Date:  2019-04-22       Impact factor: 1.472

5.  Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Dominic Stanculescu; Lars Larsson; Jonas Bergquist
Journal:  Front Med (Lausanne)       Date:  2021-01-28

Review 6.  Oxidative Dysregulation in Early Life Stress and Posttraumatic Stress Disorder: A Comprehensive Review.

Authors:  Evangelos Karanikas; Nikolaos P Daskalakis; Agorastos Agorastos
Journal:  Brain Sci       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.